. . . . . . . . "Loss of ability to dimerize. Loss of RANTES-inducing activity and ability to induce NF-kappa-B activation. Inhibition of TLR4-dependent activation of IRF3 and IRF7. Loss of interaction with TLR4." . "286"^^ . . "286"^^ . . "Mutagenesis site occurs in NX_Q86XR7-2 at amino acids 286 - 286." . . . . . "neXtProt gold" . . . . . . . . . "2014-09-19T00:00:00.0Z"^^ . . . "neXtProt database" . "CALIPHO project" . . . . . "1" . . .